BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29733234)

  • 1. Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
    Magorivska I; Döncző B; Dumych T; Karmash A; Boichuk M; Hychka K; Mihalj M; Szabó M; Csánky E; Rech J; Guttman A; Vari SG; Bilyy R
    Autoimmunity; 2018 May; 51(3):111-117. PubMed ID: 29733234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
    Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
    Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE
    Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
    Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
    Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up.
    Gudelj I; Salo PP; Trbojević-Akmačić I; Albers M; Primorac D; Perola M; Lauc G
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2034-2039. PubMed ID: 29572115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MS
    Huang C; Liu Y; Wu H; Sun D; Li Y
    Anal Bioanal Chem; 2017 Jun; 409(15):3731-3739. PubMed ID: 28397166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach.
    Bason C; Barbieri A; Martinelli N; Olivieri B; Argentino G; Bartoloni E; Beri R; Jadav G; Puccetti A; Tinazzi E; Lunardi C
    Front Immunol; 2021; 12():753400. PubMed ID: 34675934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate.
    Gińdzieńska-Sieśkiewicz E; Radziejewska I; Domysławska I; Klimiuk PA; Sulik A; Rojewska J; Gabryel-Porowska H; Sierakowski S
    Adv Med Sci; 2016 Sep; 61(2):193-197. PubMed ID: 26876088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
    Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
    Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis.
    He X; Zhong W; McCarthy TG; Weyand CM; Goronzy JJ
    Arthritis Rheum; 1996 Sep; 39(9):1499-506. PubMed ID: 8814061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis.
    Tang W; Matsumoto A; Shikata K; Takeuchi F; Konishi T; Nakata M; Mizuochi T
    Glycoconj J; 1998 Sep; 15(9):929-34. PubMed ID: 10052597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS
    Sun D; Hu F; Gao H; Song Z; Xie W; Wang P; Shi L; Wang K; Li Y; Huang C; Li Z
    Analyst; 2019 Mar; 144(6):2042-2051. PubMed ID: 30714583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
    Fernandes-Cerqueira C; Renard N; Notarnicola A; Wigren E; Gräslund S; Zubarev RA; Lundberg IE; Lundström SL
    Sci Rep; 2018 Dec; 8(1):17958. PubMed ID: 30560888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
    Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
    PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.
    Ercan A; Cui J; Chatterton DE; Deane KD; Hazen MM; Brintnell W; O'Donnell CI; Derber LA; Weinblatt ME; Shadick NA; Bell DA; Cairns E; Solomon DH; Holers VM; Rudd PM; Lee DM
    Arthritis Rheum; 2010 Aug; 62(8):2239-48. PubMed ID: 20506563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.
    De Winter LM; Geusens P; Lenaerts J; Vanhoof J; Stinissen P; Somers V
    Arthritis Res Ther; 2016 Jun; 18(1):130. PubMed ID: 27267896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
    Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
    Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis.
    Wang JR; Gao WN; Grimm R; Jiang S; Liang Y; Ye H; Li ZG; Yau LF; Huang H; Liu J; Jiang M; Meng Q; Tong TT; Huang HH; Lee S; Zeng X; Liu L; Jiang ZH
    Nat Commun; 2017 Sep; 8(1):631. PubMed ID: 28931878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
    van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.